Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-03

Clinical Trial Update: Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Celebrex to Tramadol for chronic lower back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELEBREX (Celecoxib)
  • Tramadol (tramadol)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Back Pain | Phase 4 | Status: COMPLETED